Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04309812 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current to Treat Epilepsy at Home
A NA study of Epilepsies, Partial, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 2
- Study locations
NCT04309812: Active NA study of Epilepsies, Partial, sponsored by Stanford University.
NCT04309812 is a NA study of Epilepsies, Partial that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 4 participants, below the 71-participant average among 4 other Epilepsies, Partial trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04309812, a NA study of Epilepsies, Partial, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a placebo-controlled study of feasibility and potential effectiveness of transcranial direct current stimulation (tDCS) in the home environment to reduce seizures and EEG spikes.
Primary Outcome
Number of seizures recorded in the patient diary
Conditions Studied
Interventions
- DEVICE transcranial direct current stimulation (tDCS)
Study Locations (2)
California
- Stanford Hospital - Stanford
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-05-26 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What the registry record for NCT04309812 still lists
NCT04309812 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 71-participant average among 4 other Epilepsies, Partial trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Epilepsies, Partial appearing as the primary indexed condition, and to 1 intervention - of which transcranial direct current stimulation (tDCS) is the first listed.
NCT04309812 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04309812 about?
NCT04309812 is a clinical study titled "Transcranial Direct Current to Treat Epilepsy at Home". This is a placebo-controlled study of feasibility and potential effectiveness of transcranial direct current stimulation (tDCS) in the home environment to reduce seizures and EEG spikes.
What is the current status of trial NCT04309812?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2021-05-26. Estimated completion is 2027-06-30.
What conditions does trial NCT04309812 study?
This clinical trial studies the following conditions: Epilepsies, Partial.
What interventions are being tested in trial NCT04309812?
The interventions under investigation include: transcranial direct current stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT04309812?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04309812 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsies, Partial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
COMPLETED · NA
-
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
COMPLETED · Phase 3
-
Pediatric Epilepsy Study
COMPLETED · Phase 3
-
Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI